๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects

โœ Scribed by WUTTKE, H; RAU, T; HEIDE, R; BERGMANN, K; BOHM, M; WEIL, J; WERNER, D; ESCHENHAGEN, T

Book ID
111727943
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
120 KB
Volume
72
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

No evidence of increased adverse drug re
No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline
โœ Rebecca L. Roberts; Roger T. Mulder; Peter R. Joyce; Suzanne E. Luty; Martin A. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

## Abstract The polymorphic enzyme cytochrome P450 CYP2D6 is involved in the metabolism of many antidepressants, including nortriptyline and fluoxetine. Some 7%โ€“10% Caucasians have inactivating mutations in both alleles of the __CYP2D6__ gene, and are referred to as poor metabolizers (PMs). Several

Effect of the cytochrome P450 2D6*10 all
Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients
โœ Yutaro Suzuki; Naoki Fukui; Nobuto Tsuneyama; Junzo Watanabe; Shin Ono; Takuro S ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB

Objective The sum of the serum levels of risperidone (RIS) and 9-hydroxyrisperidone (9-OH-RIS), which is the active moiety serum level, could be important for estimating the clinical effects of RIS. However, there have been no consistent results reported about the relationship between cytochrome P45